NDC 51662-1564-02 - ZIPRASIDONE MESYLATE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51662-1564
Requested NDC
51662-1564-02
Package NDCs from labels
51662-1564-2, 51662-1564-3, 51662-1564-02
Manufacturer
HF Acquisition Co LLC, DBA HealthFirst
Effective date
2024-01-30
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ZIPRASIDONE MESYLATE - HF Acquisition Co LLC, DBA HealthFirstHF Acquisition Co LLC, DBA HealthFirst2024-01-30HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1564-2ZIPRASIDONE MESYLATE1 in 1 POUCHINJECTION, POWDER, LYOPHILIZED,12
51662-1564-2ZIPRASIDONE MESYLATE5 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,52
51662-1564-3ZIPRASIDONE MESYLATE10 in 1 CASEINJECTION, POWDER, LYOPHILIZED,102

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1564ZIPRASIDONE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]2Current NDC, Legacy NDC, 3 package rows20240201_c75971f8-9640-a6e8-e053-2995a90af654.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ziprasidone MesylateZIPRASIDONE MESYLATESTERISCIENCE SPECIALTIES PRIVATE LIMITED1ffd16c3-25ac-4839-9ea9-4efd32926b952025-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATENovadoz Pharmaceuticals LLC90b35a26-ab65-4c39-b97f-55c8c0e34b0b2025-08-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 351223
unii: 3X6SAX83JZ
Ziprasidone MesylateZIPRASIDONE MESYLATEFosun Pharma USA Inc.b28a4f3d-0aae-050d-e053-2995a90aa4a62025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA211908
rxcui: 351223
unii: 3X6SAX83JZ
Ziprasidone MesylateZIPRASIDONE MESYLATEFosun Pharma USA Inc.90f55022-8d58-4bfb-9464-9bf11395ae172025-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA211908
rxcui: 351223
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATEGland Pharma Limited77a10f48-e300-465f-81b5-54be38daa4b32025-03-13Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA211908
rxcui: 351223
unii: 3X6SAX83JZ
ZIPRASIDONE MESYLATEZIPRASIDONE MESYLATEHF Acquisition Co LLC, DBA HealthFirstc75971f8-9640-a6e8-e053-2995a90af6542024-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA211908
ndc (package): 51662-1564-2
ndc (package): 51662-1564-3
ndc (product): 51662-1564
ndc11 (package): 51662156402
rxcui: 351223
spl id: 1035b793-4301-3cb4-e063-6294a90a5b1f
spl set id: c75971f8-9640-a6e8-e053-2995a90af654
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATEDr.Reddy's Laboratories, Inc.3cb79985-1207-602e-2dda-a118133b4c602021-07-30Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA211908
ndc (product): 43598-848
rxcui: 351223
spl id: 44d8fcde-2e03-b6e8-d5dd-d062e075be8c
spl set id: 3cb79985-1207-602e-2dda-a118133b4c60
unii: 3X6SAX83JZ
ziprasidone mesylateZIPRASIDONE MESYLATEDr.Reddy's Laboratories, Inc.6fd6fc45-20c4-e223-3532-ce37aa02b71c2021-07-30Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA211908
rxcui: 351223
unii: 3X6SAX83JZ

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.